22 Dec 2025
Shardul Amarchand Mangaldas, Khaitan, Cyril Amarchand Mangaldas and Trilegal Advise on NephroPlus ₹871 Crore IPO
"Shardul Amarchand Mangaldas advised NephroPlus, Khaitan & Co advised promoter selling shareholder Investcorp, Cyril Amarchand Mangaldas advised selling shareholder IFC, and Trilegal advised the book-running lead managers on NephroPlus's ₹871.048 crore IPO (₹353.405 crore fresh issue; ₹517.643 crore OFS). NephroPlus is Asia’s largest dialysis network, operating over 490 clinics."